This study was designed to determine if CBF derived from ASL perfusion imaging could be used to quantitatively evaluate the MVD of brain gliomas on a “point-to-point” basis. The study enrolled 47 patients with treatment-naive brain gliomas who underwent preoperative ASL before stereotactic surgery. We histologically quantified MVD from CD34-stained sections of stereotactic biopsies and co-registered biopsy locations with localized CBF measurements. CBF showed a statistically significant positive correlation with MVD. ASL can be a quantitative and noninvasive perfusion MR method for evaluating the MVD of brain gliomas, and may reflect the microvascularity of gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords